Adrian Ho

Adrian Ho is a Principal Investigator and Senior Principal Scientist at Chugai Pharmabody Research since February 2014, where involvement includes leading projects in the Pharmacology Unit. Prior to this role, Adrian Ho worked at A-STAR from July 2011 to January 2014 as a Principal Scientist and Research Fellow, focusing on immune modulation by vaccine adjuvants, therapeutic strategies for inflammasome-mediated diseases, and innate inflammatory mechanisms related to gout. Earlier experience includes serving as a Research Assistant at the National University of Singapore from July 2006 to August 2007. Adrian Ho holds a PhD in Immunology and a Bachelor of Science in Life Sciences from the National University of Singapore, completed in 2011 and 2006, respectively.